Canada: Esteemed Chair, Ministers, Heads of Delegation, Distinguished Delegates, and Civil Society Representatives: Canada is experiencing one of the most serious public health crises in our country’s history: an unrelenting toxic drug and overdose crisis. The impact and scope of the toxic drug crisis is devastating and more complex than ever. Tragically, we have seen an increase in overdose deaths and harms for almost a decade now. The supply of unregulated drugs in Canada is unpredictable, dangerous, and increasingly toxic. Highly potent synthetic opioids such as fentanyl are ubiquitous and other substances are being found in the unregulated drug supply at increasing rates. Canada is committed to taking actions at all levels to prevent overdose and save lives. This includes new and innovative strategies to address clandestine synthetic drug production and consideration cross-cutting issues like poverty and housing. Our approach to these commitments is outlined in detail in the Canadian Drugs and Substances Strategy. This Strategy represents our comprehensive, compassionate, equitable and collaborative approach to drug policy that balances both public health and public safety objectives in addressing substance use harms. Mr. Chair, each new substance identified in Canada’s illegal unregulated drug supply introduces new challenges to law enforcement, regulators, communities, and service providers at the frontline of the overdose and drug poisoning crisis. To address these challenges, Canada supports evidence and data-based efforts that focus on improving information sharing, strengthening access to harm reduction services, and equipping law enforcement with the tools they need to disrupt the illegal unregulated drug market. These actions must be balanced with comprehensive health and social supports that are evidence- and human rights-based. Each and every individual impacted by substance use should have access to the support they need. It is also critical that we advance drug policy that respects human rights and dignity, and recognize the disproportionate impact of the overdose crisis on marginalized communities. Canada continues to advance drug policy that respects human rights and recognizes the disproportionate impact that drug policies can have on populations marginalized on the basis of race, ethnicity, age, gender, and sexuality. It is also vital that we address stigma and recognize how it creates barriers to care. Canada therefore welcomes the latest Human Rights Council resolution on drug-related matters, as well as the resulting report on drug policy and human rights from the Office of the High Commissioner for Human Rights. There is no denying that the emergence of new psychoactive substances has challenged our ability to adapt and respond to evolving drug trends. Our experience has demonstrated a need for coordinated and reliable data collection and better information sharing systems. We need robust early warning systems to help recognize and mitigate these challenges before they worsen. Canada underscores that global cooperation is imperative. We value our partnerships with UNODC, Member States, civil society organizations and people with lived and living experience to help strengthen Canada’s capacity to address the toxic drug supply. Canada reaffirms its commitment to transparency and collaboration with UNODC and supports the efforts of the Global Coalition to Address Synthetic Drug Threats. We look forward to the discussions at this High-Level Segment of the Midterm Review and hope we can collectively strengthen our cooperation and efforts to protect the human rights, health, and safety of all. Canada also condemns the ongoing, illegal and immoral invasion of Ukraine by Russia. This blatant violation of international law has catastrophic humanitarian consequences, including in addressing the world drug problem. Canada also calls for Hamas to release all the hostages, mourns the loss of innocent lives in Gaza and Israel and to stop using Palestinians as human shields. Ultimately a negotiated political solution is needed to achieve a better future for both Israelis and Palestinians. With a view to enhancing the implementation of international drug policy commitments, I pledge for Canada to continue to advance drug policy that respects human rights and recognizes the disproportionate impact that drug policies can have on marginalized populations, including on women and girls. Canada’s approach to substance use and the overdose crisis includes a comprehensive public health and public safety response, as outlined in our recently renewed Canadian Drugs and Substances Strategy. Canada is focused on taking action across the full continuum, including harm reduction and treatment; prevention, stigma reduction and increasing awareness of harms; further building the evidence base on effective interventions; and strengthening enforcement to address illegal drug production and trafficking. Colleagues, we must continue to be both compassionate and brave in this work. We must continue to see and support our most vulnerable and marginalized who struggle under the weight of trauma mental health and the poisoned illegal toxic drug supply. We must do this work to save lives and to work collaboratively in our global efforts – for to save a life is to save a world in of itself of mothers fathers, brothers sons and daughters – whole communities who look to us to meet the challenges of today and to create the pathways for healing and recovery for them now and in the future – through health – not punitive measures, and through our collective work to save lives. Thank you.

Lithuania: Mr. Chair, Excellencies, Distinguished delegates, Ladies and gentlemen, Lithuania fully aligns itself with the statement delivered on behalf of the European Union. In my national capacity, let me highlight the following points. Lithuania remains committed and supports global efforts to address the world drug problem. In 2019, Lithuania pledged to accelerate the implementation of all its international drug policy commitments. To achieve this goal urgently, the Lithuanian Parliament adopted the long-term National Agenda for Drug, Tobacco and Alcohol Control, Consumption Prevention, and Harm Reduction until 2035. This agenda serves as a roadmap for Lithuania to achieve the relevant global goals. Our National Agenda’s approach is based on understanding the multifaceted nature of drug problems, having an impact on many areas of life, communities, and public governance. Therefore, the national agenda and measures to solve drug-related problems are an integrative document, which should become a part of strategic action plans in every sector. Our vision focuses on the protection of the inherent dignity of every individual affected by drug related issues. An evidence-based, integrated, balanced, and multidisciplinary approach must serve as the foundation upon which we build our responses to the complexities of the drug trade. Also, our actions should be just, equitable and respectful of the principles enshrined in international policy documents. I believe that by adopting a human rights-oriented, integrative, balanced, multidisciplinary, and evidence-based approach, we can address the roots and causes of the drug problem and pave the way for a more compassionate and effective response. Mr. Chair, the UNGASS Outcome Document places significant emphasis on advancing a collective vision that aims to enhance the health and well-being of humanity. Lithuania acknowledges this, and the Document has become an important impulse for our National Agenda. The cooperation of states in tackling the drug problem, establishing common goals, and initiatives pledging action have great potential and transformative effects. On behalf of Lithuania, I thank the Commission on Narcotic Drugs and distinguished delegates for their work that instigates change. And finally, Lithuania’s pledge With a view to enhancing the implementation of all international drug policy commitments, and in addressing the challenges declared in 2019 Ministerial declaration, the Lithuanian Republic pledges until 2029 to establish a national coordination and monitoring mechanism for the assistance and services provided to individuals suffering from addiction disorders, aiming to increase accessibility to medical, psychological, reintegration, and social assistance services. Thank you for your attention.

United Kingdom of Great Britain and Northern Ireland: Introductory Remarks Chair and distinguished guests, I will start by re-affirming the UK’s support for Ukraine in the face of Russia’s unprovoked aggression. Alongside our allies, we stand with the Ukrainian people. Turning to the subject of this session, we know that illicit drugs have a devastating impact on individuals and communities. UK Drug Strategy The UK Government’s approach to drug misuse is underpinned by a comprehensive 10-year strategy with three strategic priorities: breaking drug supply chains, delivering a world-class treatment and recovery system and achieving a generational shift in the demand for drugs. Our balanced approach is already seeing success. In the first full year of delivery, the UK’s law enforcement agencies have seized record levels of cocaine, both at the UK border and inland, and made over 2,600 arrests. We have expanded the use of drug testing on arrest across police forces and increased the numbers of referrals into treatment from the criminal justice system by 8%. And action in the treatment and recovery space is taking effect across the UK. In Wales over 1,600 people are now being treated with injectable buprenorphine; in Northern Ireland a new 10-year substance misuse strategy has been published; in Scotland new Medication Assisted Treatment standards have been developed; and in England, national guidance on recovery support and lived experience, and standards for peer-led organisations have been produced. Working internationally While the specific issues may differ from country to country, we are all grappling with emerging challenges, including online drug markets, the potential of artificial intelligence to transform the way criminals operate and synthetic drugs. I value the work of UNODC, the INCB, Interpol, the World Health Organisation, Civil Society and other multilateral initiatives, such as the US-led Global Coalition on Synthetic Drugs, in driving forward collaborative solutions. 2 Synthetic Drugs In the UK, we have established a Synthetic Opioids Taskforce to tackle the emerging threat of synthetic drugs and I will be hosting a side event at 11am on sharing different perspectives on responding to synthetic opioids, I hope to see many of you there. Pledge4Action Tangible action is needed to see results and that is why I welcome the Chair’s Pledge4Action initiative. I have already spoken about the UK’s commitment to tackling the supply of illicit substances, including their cultivation, production, manufacture and trafficking, and that is why I pledge for the United Kingdom to work closely with global partners such as Interpol to build capacity and invest in law enforcement programmes and activities in tackling drug supply. Additionally, to improve drug treatment and health services, I pledge, by delivering the Addiction Mission, to make the UK a place where researchers and innovative companies can thrive and partner effectively with the National Health Service and charity-led treatment services to design, research and deploy novel treatments and technologies which effectively tackle the challenges of drug and alcohol addictions. Through this we will improve the lives of those affected by these addictions, reduce the harms to the individual, their family and friends, and to wider society in the UK and globally. I also pledge for the UK to ensure that drug and alcohol treatment and recovery support services are evidence-led, more widely available and include independent peer-led support to help people to sustain recovery long term and to listen to the voices and expertise of people with lived and living experience, and their families, across our drug strategy programmes and projects. Thank you.

Malta:Mr Chair, Excellencies, Distinguished Delegates, Representatives of Civil Society, Malta aligns itself with the statement delivered on behalf of the European Union. Allow me to make some remarks in my national capacity. Mr. Chair, Malta stands firm in its unwavering supporting for the International Drug Control Framework, including the relevant Conventions and the commitment to implement the agreed international drug policy commitments. It is my Government’s firm conviction that this broad framework is guided by the overarching principle to safeguard, protect and promote the health and welfare of our societies, as enshrined in the Preamble to the 1961 Single Convention on Narcotic Drugs. Moreover, it is this principle, which has guided our own national review process, which yielded the Malta National Drugs Policy (2023-2033). The updated strategy has sought to build on what has worked and also address emergent issues that have come to the fore, in Malta. Particular focus has been placed on the need to bolster and further invest in our Prevention Services, as well as that to boost our support for Law enforcement actors. In this respect, coordination bodies are being established to ensure the representation and engagement of all pertinent Ministries, Government authorities and partners, in the decision-making process. An Inter-Ministerial Committee on Drugs issues has already been established in 2023, to harmonize coordination and cooperation on CND matters, in view of our current membership. Additional resources are being allocated to Law Enforcement to build capacity, including the Malta Police Drugs Squad, the Cyber Crime Unit, the Financial Intelligence Unit, as well as the Asset Recovery Bureau and the responsible Tax and Customs authorities. The aim of these targeted actions is to further strengthen the reduction of the supply of illicit drugs, and efforts to combat organized criminal networks and drug trafficking groups. 2 Mr. Chair, We believe that our primary responsibility to people who live in Malta, is to ensure respect for the basic human rights to equitable health and adequate care, and to reduce the use of drugs and their related risks and harms, for ALL members of society. We will endeavor to discuss these issues during the side event being organized by the Permanent Mission of Malta in Vienna, which I hope many of you will be able to participate in, which will be held on Monday, 18th March 2024 at 09:10 a.m. Mr. Chair, We also remain committed to broadening and deepening our treatment and recovery services for People Who Use Drugs, and People with Substance Use Disorders. With a view to enhancing the implementation of all international drug policy commitments, and in addressing the challenge that drug treatment and health services continue to fall short of meeting needs and deaths related to drug use have increased, I pledge for Malta to invest and improve further harm reduction services, through the establishment of a Low threshold unit in which all may use when running into issues related to their drug use;; by enhancing capacity-building and training for medical workers, social workers, youth workers, psychologists, counsellors and psychotherapists on addictive behaviour; and by establishing more community outreach. We remain committed to keeping the international drug community abreast of progress made, in implementing our national policy commitments. We will provide the Commission with an update on efforts in Malta during the Final Review in 2029, in a testament to our unwavering commitment to cooperation with our international partners, to strengthen our efforts to address the world drug situation. Thank you.

Iraq: Thank you very much Mr President. I’ll try to be very concise. Congratulations on your election to Chairmanship of the 67th session and I wish to congratulate other elected members. We are ready to extend our support and assistance in the discharge of tasks. We wish to align ourselves with the statements of the Group of the 77 and China and the group of Asia-Pacific states. We want to address the world drug problem in collaboration. We need to coordinate efforts to address and counter this problem. Hence we underscore the importance of fully committing to the three international drug control conventions as a cornerstone in this endeavour to counter the world drug problem in addition to other illegal instruments and relevant instruments which are complementary and mutually reinforcing. We reiterate the deep link between drug trafficking revenues and the financing of terrorism, organised crime and money laundering. We are committed to tightening borders, preventing smuggling, and prosecuting traffickers of drug and psychotropic substances in addition to dismantling criminal networks. We call to strengthen regional and subregional cooperation to rid our people and youth of this scourge. We underscore Iraq’s efforts at the national and regional levels: we have approved a national anti-narcotics effort from 2023-2025. We have formed a committee to counter drugs and psychotropic substances in the Iraqi parliament. We have formed several regional conferences to address this issue. We have also organised and hosted events at the Arab level in Baghdad held most recently in October 2023. Under the Prime Minister we have approved the establishment of rehabilitation centres for accused detainees in cases of abuse of drugs which will provide them with rehabilitation and reintegration. We have signed a number of security MOUs with regional states and neighbouring states. We underscore the importance of cooperation at this level in addition to the importance of bilateral meetings held with representatives of international organisations. Building the capacity and skills and countering these syndicates and providing the logistical support they need. Fruitful and continuous cooperation with anti-narcotic agencies within the Kyrgyzstan province led to successful joint operations and the bringing down of several important ring heads. We pay tribute to the efforts of UNODC for their effective cooperation with the Iraqi side and their field office in Baghdad. To conclude, we look forward to further bolstering the relationship with all parties, the strengthening of joint efforts at all levels. So as to further bolster the fulfilment of commitments collectively and so as we may be able to eradicate the problem of drugs, the smuggling thereof, and the countering of it internationally. Thank you, chair. [Original statement available here]

Australia: Chair, Honourable Ministers, Distinguished Representatives, It is an honour to be in Vienna, and to participate in the High-Level Segment of the 67th Session of the Commission on Narcotic Drugs. I firstly wish to acknowledge the efforts of Ambassador Johnson in chairing the negotiations of the Outcome Document of the 2024 Midterm Review – a significant undertaking and a demonstration of his determination to commence this session with a renewed commitment to improving the global drug situation for all. It has been more than two years since Russia’s illegal and immoral full-scale invasion of Ukraine. We unequivocally condemn Russia’s ongoing aggression and call for an end to all actions that undermine Ukraine’s sovereignty and territorial integrity. Russia’s aggression is a gross violation of international law and a significant threat to the rules-based order. That order – the rules and norms which we have all agreed over years of collaborative effort – underpins the international cooperation required to address and counter the world drug situation. 2 Chair, and Distinguished Delegates, Addressing the dynamic and diverse challenges posed by the global drug situation is complex, however we know there is undeniable power in coordinated effort and collective action. This year, it is vitally important that we seize the opportunity to channel our shared commitment and resolve to not only address but to improve the global drug situation for all. Australia’s longstanding commitment to harm minimisation considers the health, social and economic consequences of drug use on individuals, families and communities, and recognises that preventing or reducing the wide range of drug-related harms requires multifaceted and human rights-based responses. This is the foundation of our National Drug Strategy. Within and beyond our borders we need to increase discussion and coordinated action to implement and improve community-led and driven approaches, that are based on scientific evidence. 3 Australia reinforces the importance of ensuring actions are balanced between health and law enforcement approaches. We support actions which take into account gender equality and human rights principles and obligations, address broader social determinants, and reduce the stigma and discrimination associated with drug use. In doing this, Australia is committed to working with all relevant stakeholders, including other member states, the broader UN system, international partners, civil society and affected communities to ensure meaningful and tangible progress is made. We want to elevate the voices of those affected by drug policies and programs, in order to promote and protect rights-based and public health-driven harm reduction efforts. Australia will continue to call for global abolition of the death penalty, particularly its abolition for drug-related offences. We believe the imposition of the death penalty for drug-related offences is inconsistent with international human rights law and an ineffective deterrent. Australia is pleased to lead a side event at next week’s Regular Segment on wastewater analysis, with a view to sharing new insights and exploring how it is a complementary tool in understanding drug markets, monitoring the effectiveness of initiatives and responses, and informing policies and priorities. 4 Australia acknowledges with appreciation the leadership of the United States in driving the work of the Global Coalition to Address Synthetic Drug Threats. We welcome this partnership of more than 140 countries in bolstering international efforts to respond to, identify, and prepare for the varied and expanding threats posed. Australia remains concerned about synthetic drugs, particularly amphetaminetype stimulants, new psychoactive substances, and the diversion of precursor chemicals used to manufacture these substances. We are committed to continuing to engage constructively in the work of the Coalition, recognising the value in sharing experiences, best practice and lessons learned. Furthermore, Australia welcomes the UNODC’s #ScaleUp Initiative, and is encouraged by efforts to expand international research, bridge the global treatment gap for stimulant use disorders, and facilitate the development and implementation of scalable interventions to benefit different regions, contexts, and population groups. Distinguished Delegates, 5 We have five more years to demonstrate our impact in addressing not only the challenges outlined in the 2019 Ministerial Declaration, but other emerging challenges, trends and situations that are inextricably linked to the everevolving global drug situation. Chair, we welcome the opportunity to participate in and contribute to your Pledge4Action Initiative. I pledge for Australia to contribute to global efforts which enhance the implementation of international drug policy commitments. I pledge for Australia to join and be a leading partner in the International Narcotics Control Board’s industry mapping project aimed at preventing the diversion from chemical industries, of internationally controlled and nonscheduled chemicals, including designer precursors, for the illicit manufacture of synthetic drugs, new psychoactive substances (NPS) and controlled precursors. I pledge for Australia to ensure a range of prevention, treatment and harm reduction services are available to the Australian community, acknowledging where drug treatment and health services fall short of meeting needs and where deaths occur as a result of drug use. 6 These services need to be delivered in a variety of modalities and settings, with particular priority on tailoring services and initiatives to priority populations most affected by drug use, including young people, First Nations Australians, and clients referred from the criminal justice system. To further extend this pledge, Australia will continue to have meaningful and ongoing engagement with civil society and community-led organisations, researchers and other key stakeholders to ensure drug-related research and data is available, with particular consideration given to the Pacific region. Lastly, in addressing the fact that the rate of transmission of HIV, the Hepatitis C virus and other blood-borne diseases associated with drug use remains high, I pledge for Australia to continue its leadership in driving scientific evidencebased and community-driven action. We commit to working to eliminate the transmission of HIV, Hepatitis C and other blood-borne diseases, and ensuring affected communities can access a full range of interventions and health services that are gender-responsive, inclusive, culturally safe, and free from stigma and discrimination. Thank you.

Panama: Thank you, chair. Good morning. We thank the chair for your dedication and able leadership. Panama supports the statement by GRULAC and the statement delivered on behalf of Colombia and the G77. The abuse of NPS are empowering transnational crime. As a transit country we have made huge strides combating drugs and other forms of trafficking. We have seen an increase of both cocaine and cannabis trafficking. We have seized over 500 tons over the last few years and also dismantled a number of criminal gangs and networks. The hostile conditions of the desert, a world heritage site, that is used as a transit for the trafficking in drugs, persons, guns has disastrous impacts on the environment. To tackle these problems we have had to spend a large amount of money and this challenges our 2030 Agenda. Panama welcomes international cooperation and we need to strengthen our multilateral commitments and we thank UNODC and others who have helped train both government institutions and NGOs. The Panama Commission is a new early warning system coordinated to prove timely information to the population on health and drugs. We welcome UNODC’s International standards on drug use prevention. My country’s commitment is to tackle this scourge and the commitments to undertake the 2019 Ministerial Statement. [Original statement available here]

Uzbekistan: Mr. Chair, Excellences, Distinguished participants, Ladies and Gentlemen, First of all let me on behalf of the delegation of Uzbekistan extend our warm greetings to all participants of the Sixty- seventh session of the Commission on Narcotic Drugs (CND) and wish all of us productive discussions during this high level forum. Uzbekistan highly appreciates the important role played by the CND in the global antinarcotics movement. We are actively working as an observer and strive to further strengthen our cooperation with the Commission. Over the past few years, Uzbekistan has significantly strengthened its partnership with the United Nations Office on Drugs and Crime (UNODC) in combating drug trafficking, organized crime, corruption, human trafficking and terrorism. We also recognize the importance of bilateral cooperation in the successful implementation of anti-narcotics programs and strategies. In this context, we are currently working on various initiatives within the framework of the “Roadmap” for deepening cooperation with the United Nations and its specialized agencies. The promotion of Uzbekistan’s candidacy for membership in the CND today is one of the priorities for our country. We strongly believe that by participating in the work of the Commission we can make our own contribution to the development of comprehensive approaches to anti-narcotics cooperation at the regional and global levels. Therefore, we would like to count on the support of UN member states of our endeavor. Distinguished delegates, Now allow me to draw your attention to an important national project that we are currently implementing in Uzbekistan. This is the developing of the National Strategy for Combating Illicit Trafficking and Abuse of Narcotic Drugs, Psychotropic Substances and their Precursors. This Strategy will be a crucial instrument in our efforts in combating drugs and related with it problems. We strive to develop a comprehensive and effective approach that will cover both preventive measures and measures for rehabilitation and social reintegration. We invite the international community to support us in this process by exchanging experience and best practices in the field of drug control and to jointly tackling the challenges facing our society. In conclusion, I would like to reiterate strong commitment of Uzbekistan to expand close collaboration with the UNODC and other partners in addressing threats and challenges emanated from illegal drugs trafficking and in this regard we look forward to actively interacting with all members of the CND. Thank you for your attention.

Nepal: Mr. Chair, Allow me to express my congratulations on your election as Chair of the 67th Session of the Commission on Narcotic Drugs, and to extend my well wishes to the other members of the Bureau for their respective elections. I assure you of my delegation’s full support. While aligning itself to the statements delivered by G-77 and China and the AsiaPacific Group, Nepal wishes to add the following points in its national capacity: We take this opportune moment to emphasize and reiterate our commitment and determination to address and counter the drug problem. Nepal acknowledges the significance of reinforcing our national capacity as an integral component of the ongoing Midterm Review process. By engaging in collaborative dialogue and sharing insights on our national experiences, we aim to contribute meaningfully to the broader discourse, ensuring that our strategies align with the evolving challenges outlined in the 2019 Ministerial Declaration. Through this gathering, Nepal looks forward to actively participating, laying a robust foundation for effective drug policy implementation beyond the Midterm Review. We would also like to thank UNODC for publishing the World Drug Report 2023, which explores the complex intersections of illicit drug economies, environmental crimes, and insecurity. The invaluable contribution of this report enhances our collective understanding of the complex situations, providing a solid foundation for informed decision-making in our ongoing efforts to address the multifaceted challenges posed by illicit drugs. Mr. Chair, Nepal believes that it is crucial to intensify our efforts, collectively and globally, to combat this complex world drug problem. This includes ensuring adequate access to controlled substances for medical and scientific purposes, while preventing their diversion into illicit channels. Nepal reiterates its commitment to all three international drug control conventions Nepal is also committed to implementing the goals set by the 2019 Ministerial Declaration, the UNGASS 2016 Outcome Document, and the 2009 Political Declaration and its Plan of Action. Our commitment to reducing drug abuse and implementing a comprehensive and balanced national drug control strategy is aligned with our developmental aspirations, including the SDGs. Nepal has enacted The Narcotic Drugs (Control) Act 2033 (1976) which provides a comprehensive legal framework to regulate the production, sale, and consumption of narcotic drugs in Nepal. Nepal has established a comprehensive framework for drug control through the National Policy for Drug Control 2006. The overarching vision of this policy is centered on the “Attainment of a Healthy and Prosperous Society Free from Drug Addiction.” The policy strategically addresses various facets of drug control, encompassing supply control, demand reduction, treatment and rehabilitation, risk reduction, research and development, collaboration and partnership, as well as resource mobilization. By integrating these key components, the policy aims to create a holistic and effective approach to combat drug-related challenges, ensuring the wellbeing and prosperity of society while fostering a drug-free environment. Nepal has implemented effective regulatory practices for precursor chemicals, establishing a closely monitored system overseen by the Chief Narcotic Controller. Nepal’s Drug Control Strategy 2010 implements targeted programs, including community-based initiatives and specialized efforts for women, children, and youth. The strategy also emphasizes a Social Integrity Program, promoting a cohesive societal environment to combat drug-related challenges effectively. This comprehensive approach aims to address the diverse needs of the population in the fight against substance abuse. Mr. Chair, We request UNODC, other relevant UN entities, and the international community to provide appropriate technical cooperation to developing countries, particularly the LDCs, to tackle drug issues while ensuring the implementation of SDGs. Nepal emphasizes the significance of our efforts for the 2024 mid-term evaluation of the 2019 Ministerial Declaration. We reaffirm our firm commitment to the evaluation process, considering it a valuable opportunity to review the progress achieved, identify ongoing challenges, and formulate a practical strategy for the future. Thank you, Chair.

Guatemala: Chair. My delegation would like to congratulate you on your election to lead our work on the 67th session of the CND and offer you our full support. We would also like to greet the executive director of the UNODC and commend the work of the secretariat. Guatemala recognizes that the world drug problem poses issues that need to be addressed by multisectoral solutions. We must combat the illicit trafficking of drugs. We have had a lot of international coordination for analysis and exchange of information for carrying out operations to seize drugs. Guatemala is a regional leader when it comes to addressing precursors. We have been working in Central America since 2018. Guatemala in recent years has preceded over two inter-American working groups for the control of the abuse of drugs and destruction of precursors. Tackling the global drugs problem must consider shared responsibility to strengthen international cooperation. In order to contribute to achieving our goals we have committed to three commitments: 1) commit tot drawing up a protocol for action in the first quarter of 2024 to strengthen inter-institutional cooperation in the monitoring and distribution of chemical precursors; 2) we are going to make an early warning system to provide a timely response to new problems linked with synthetic drugs. Strengthening of this system will include perfecting the procedures and systems for communicating to ensure results are timely and we can adopt appropriate measures to tackle it. 3) We are committed to the framework of the chance initiative and working within this to prevent drug use in adolescents and childhood. We are reaffirming our commitment to tackle this scourge which affects us so greatly. Thank you. [Original statement available here]

United Arab Emirates: Thank you sir. Mr Chair. Ladies and gentlemen and esteemed delegates. We congratulate you on your  election and thank UNODC and INCB and all the other organisers of this meeting. 

We meet today to implement the commitment of the 2019 Ministerial Statement and our joint commitments to address the world drug problem. We express grave concern in the trafficking of drugs and psychoactive substances. We have implemented a series of programs implemented nationally according to international commitments. We are forced to confront the trafficking of illegal drugs, often through the internet and social media. We have developed strategies to prevent youth from using drugs, including social media and workshops in cooperation with UNODC and law enforcement working with students in the schools, and we have confiscated over 30,000 drugs (?). We commend the global coalition on synthetic drugs. The UAE will host the UN conference CCPJ in 2026 and will run a number of other events, conferences and workshops in and around the CCPJ. We wish you all success in your efforts here and peace be on you. [Original statement available here]

France: Ladies and gentlemen. France supports, and is aligned with, the EU statement in its entirety. The relevance of addiction and its changing nature via the internet is of grave concern.  France is worried about new psychoactive stimulants as we don’t yet have the treatment to address. Also concerned about the opioid crisis in North America and welcome the synthetic drug coalition and it’s strategy. Production of drugs pollutes and fuels environmental crimes. We need a joint response from the international community. Referencing the 2026 UNGASS Outcome document, we are committed to prevention. The international drug conventions are aligned with human rights obligations and we call on all governments still using the death penalty to work to abolish it. We support UNODC and it’s leader, Ms. Gada Waly. We propose implementing early prevention; breakthrough programs and rising to challenges of HIV and other BBVs and we will continue to support UNIADS. We have increased our funding to UNAIDS. We are setting a national regime of freezing the assets of the criminal gangs to short fuse their access to funds. [Original statement available here]

Argentina: Chair, dear colleagues. It’s an honour for me to once again represent Argentina in the 67th session. I would like to reiterate our commitment to tackling the world’s drug problem from the principle of common and shared responsibility with a balance between reducing demand and supply. The growing world drug’s problem, where those affected by drug use disorders according to UN data have increased by 45% over the past ten years, has political, economic and social implications. This is a complex dynamic which requires a holistic and multidisciplinary approach to consumption. At this moment our democracies are threatened by the activities of criminal organisations so we must strengthen the rule of law. Our freedom cannot be enjoyed without the right context. This is a phenomenon that extends beyond international borders and so the Southern hemisphere has been making efforts and progress on public policy including evidence-based interventions within our context. My country is strengthening international cooperation and collaboration with UNODC and other UN agencies. Moreover, Argentina supports the statement made by GRULAC in which we actively participate in the global coalition to tackle the threat of synthetic drugs. We are convinced by the importance of this coalition. Chair, we are currently meeting to carry out a midterm review of commitments undertaken under the 2019 ministerial declaration. Progress has been made but there are still challenges. This meeting is important when it comes to outlining strategies to accelerate implementation. It is essential that international organisations develop cooperation and improve policies that are sustainable. After a four year cycle without a formal strategic plan we are working on a national strategic plan and it sets out over the next four years including medium and long term strategies that are technically and methodologically sound lining up with other strategies. We welcome these spaces for dialogue that promote an exchange of views and strengthen international cooperation.That said and with a view to improving the implementation of all international commitments and to tackle the challenge that we face in terms of our treatment services for people with problematic substance use being insufficient, Argentina pledges to dedicate its efforts to strengthening over the next three years treatment systems and coordinating tools to be part of comprehensive system in line with the current standards to guarantee continuity of care for all of its citizens. [Original statement available here]

Finland: Mister Chair, Honourable Ministers and Heads of Delegations, Excellencies, Ladies and Gentlemen, Finland fully aligns itself with the statement made by the European Union on behalf of its Member States. I make the following remarks in my national capacity. Mr. Chair, Regrettably, international cooperation in the UN system continues to be severely hurt by Russia’s illegal, unprovoked and unjustified war of aggression against Ukraine. Finland stands in full solidarity with Ukraine and firmly supports Ukraine’s independence, sovereignty and territorial integrity. The Mid-Term Review process has reminded us that many challenges remain, evolve and new challenges arise. Almost 10 years after UNGASS we still need to improve our efforts and adjust our approaches in line with the International Drug Control Conventions and human rights obligations. For drug policies to be effective, we need further efforts to protect human rights, including measures to reduce stigma and discrimination. We also need to promote gender transformative approach that takes into account the needs of LGBTI persons. Mr. Chair, In Finland, our strengths to tackle drug supply and drug-related crime include close and wellstructured cooperation between the Police, Customs and Border Guard. Law enforcement and other relevant authorities gather and maintain criminal intelligence. Situational intelligence is analyzed and responded together in coordinated manner. 2(2) We are aware of the emerging challenges such as new trafficking routes, production methods, polysubstance use and the use of new substances. We should not shy away from new threats and challenges even though it seems sometimes that we are two steps behind. We know that technological developments can be used to enhance criminal activities, but they can be used also to our advantage. Internet is an important environment for demand reduction interventions. It can enhance access to prevention, counselling and treatment services, as well as risk and harm reduction. Mr. Chair, Experience has taught us that to achieve the best results in drug policy we need multisectoral and balanced cooperation. Social, health and law enforcement authorities as well as other stakeholders must work together. This cooperation includes the scientific community, non-governmental organisations, grass root actors and people who use drugs. Implementing drug policy is not a competition between different actors. Thank you Mr Chair (With a view to enhancing the implementation of all international drug policy commitments, and in addressing the challenge that drug treatment and health services continue to fall short of meeting needs, and deaths related to drug use have increased) — Finland pledges to provide annual funding of 8 million euros for national efforts to prevent drug related deaths and support youth who struggle with substance use and drug-related violence. These measures are coordinated and implemented in intersectoral co-operation with different actors. Thank You.

Indonesia: Excellencies, Ladies and gentlemen, I extend my congratulations to Ambassador Philbert Akaba Johnson for assuming the esteemed role of Chair for the 67 th session of the Commission. Please accept the assurances of my delegation’s unwavering support for your leadership in chairing this session. Indonesia aligns itself with the statements made by ASEAN, the Group of 77 and China, as well as the Asia-Pacific Group, and would like to add the following in its national capacity. Excellencies, As we convene for the 67th session of the Commission on Narcotic Drugs, we find ourselves at a critical juncture in the global effort to address the challenges posed by illicit drugs and their harmful impacts. The COVID-19 pandemic recovery has exacerbated the ongoing drug crisis, which has profound effects on the entire world. From rising rates of substance abuse to the increasing use of technology and cryptocurrency in drug trafficking, the pandemic underscored the interconnected nature of the health, social, economic, and security challenges posed by illicit drugs. Our collective response must be guided by compassion, solidarity, and a commitment to leave no one behind. On this important occasion, please allow me to focus our attention on several key priorities: First and foremost, we must strengthen our efforts to promote public health and reduce harms related to drug abuse, illicit drug cultivation, production, manufacture, and trafficking. – Such measures include concrete actions regarding education, prevention, post-rehabilitation and/or aftercare programs. – This requires expanding access to evidence-based prevention, treatment, and harm reduction services, particularly for vulnerable populations. Improving accessibility to rehabilitation services for drug abusers through community-based interventions aims to enhance support for individuals in need. – We must prioritize the integration of drug treatment and mental health services to ensure that no one is denied access to life-saving interventions. – Indonesia has collaborated with the UNODC to implement best practices in prevention standards adapted from the UNODC’s Family United module, aligning with Indonesian cultural values. It provides training for drug prevention practitioners and is piloting the implementation of these adaptations with an updated module. Second, enhancing national coordination and efforts to reduce demand. – Indonesia prioritizes education and prevention in combating drug abuse, investing in raising awareness, and empowering individuals to make informed decisions. – The government also continues to conduct measurements of vulnerable areas, focusing on supply reduction, demand reduction, and vulnerability factors. – Indonesia is currently revamping its drug policy laws, aiming for an integrated approach to ensure effectiveness in addressing the national drug situation. – Indonesia’s adherence to global prevention standards within its domestic strategies signals a deep commitment to safeguarding the overall wellbeing of its people. Third, advancing international cooperation and collaboration in reducing global supply. – The illicit drug trade knows no borders, and our response must be equally borderless. – Information sharing is essential, particularly for intelligence and law enforcement coordination, to disrupt drug trafficking networks and stem the flow of illicit drugs across international borders. – Indonesia was honored to host the 45th Session of the Heads of National Drug Law Enforcement Agencies Asia and the Pacific (HONLAP) in October last year as part of our effort to strengthen partnership in the region. Fourth, address the emerging challenges posed by new psychoactive substances and other novel drugs. – These substances present unique risks and require innovative approaches to regulation, monitoring, and public health responses. – We urgently need to identify emerging trends, assess the impact of new substances, and develop timely responses to protect public health and safety. – The international community must take steps to identify the dynamics of global value chains in precursor tracing. Finally, recognizing the important role of partnerships with relevant stakeholders, including the private sector, civil society, academia, and affected communities, in shaping effective drug policies. – Their expertise and experiences are invaluable assets in our collective efforts to address the complex challenges of drug control. – This is to ensure meaningful engagement and partnership with these stakeholders, fostering a culture of dialogue and shared responsibility. Excellencies, Ladies and gentlemen, As we gather today in this commission, let us reaffirm our commitment to a balanced, evidence-based, and multi-stakeholder approach to drug policies. Let us seize this opportunity to redouble our efforts, strengthen our partnerships, and advance our shared goal of a world free from the harms of illicit drugs and psychotropics. Together, we can build healthier, safer, and more resilient communities for generations to come. Thank you.

Tajikistan: Dear Mr. Chairman, Dear delegates, Ladies and Gentlemen, Above all, let me, on behalf of the delegation of the Republic of Tajikistan, welcome all participants at Regular Session 67 of the UN Commission on Drugs and Crime and wish fruitable work. Tajikistan recognizes that the three UN drug control conventions are the framework of the international drug control system and articulates its full support for the efforts of the participating countries in their implementation. I am confident that the High-Level Segment will make an important contribution this year to the mid-term review and subsequent fulfilment of the Ministerial Declaration 2019. It is important to note that illicit drug trafficking stays one of the world’s most pressing challenges without territorial, national or other boundaries. Combating drug trafficking, as a manifestation of transnational crime, is one of the priorities of the state policy of the Republic of Tajikistan. We are confident that the development of international relations will contribute to a constructive dialogue on the exchange of professional experience, and the decisions taken will help preserve the health of people and foster the sustainable development of our states. Dear session participants, Tajikistan is at the forefront of the fight against smuggling of drugs from Afghanistan along the Northern Route. The drug situation in our country largely depends on the situation processes and trends in Afghanistan – the country Tajikistan has a long border. Analysis of the global drug situation shows that in order to meet demand in the consumer market, more and more illegal laboratories are being run in producing countries for the manufacture of synthetic drugs such as methamphetamine. It should be noted that given this process, the threat to the countries of Central Asia, in particular to the countries bordering Afghanistan, is progressively growing since the psychotropic substance methamphetamine seized in the region is produced in Afghanistan. I would like to reiterate that narcotic drugs are not produced in Tajikistan, and not a single fact of the existence of clandestine drug laboratories has been recorded in the country. Our projection of the situation on narcotic drugs, as well as their smuggling along the Northern route, has been confirmed by the intensified recourse to this route. It is important to stress that over the past two years, the production and smuggling of drugs through our country has increased significantly. Also, the enlarged amounts of drugs seized in Tajikistan can be evidence of the available in the northern provinces of Afghanistan of great stocks of drugs, intended for shipment along the Northern Route. Given the measures taken by our Government to strengthen the Tajik-Afghan border control by construction of new border facilities (outposts), smugglers have to assess the situation and explore the possibility of trafficking in drugs to Tajikistan. Dear Session participants, The Leader of the Nation, the President of the Republic of Tajikistan, His Excellency Emomali Rahmon, has taken a number of urgent measures to hold the drug situation, block drug smuggling channels and curb drug illicit traffic and drug abuse. An important and comprehensive document in this area is the National Drug Control Strategy for 2021-2030. The main goals of the National Strategy are to ensure the security of the Republic of Tajikistan from drug threats and their harmful consequences, as well as to strengthen the combat against illicit drug trafficking, which is one of the sources of financing of international terrorism. Ladies and Gentlemen, In conclusion, supporting the initiative of the Chair of Regular Session 67 of the UN Commission on Narcotic Drugs and Crime, Tajikistan assures of its commitment to the three fundamental UN conventions, which are the pillars of the international drug control system, and the Ministerial Declaration 2019, and will make every effort to prevent drug smuggling into the country through state border and subsequent movement of illicit drugs along the Northern Route. Thank you for attention.

Republic of Korea: Thank you, Mr. Chair, On behalf of Korean delegation, I would like to sincerely congratulate you on leading the High-level Segment of the 2024 Mid-term Review as well as the Sixty-Seventh CND with a big thank you to the UNODC secretariat for successfully organizing these meaningful events as well. It is a great honor for my delegation to attend this timely segment for the global review about achievements and challenges in fulfilling all commitments set out in the 2019 Ministerial Declaration. I hope our global discussion on current drug crisis will lead us to a momentum to speed up the implementation of international counternarcotic resolutions until 2029 by actively exchanging our various experiences and lessons with each other. Mr. Chair, As head of my delegation with a top position to guide national drug policies and law enforcement in Korea, I am proud to say my government has always strived to be in the forefront of combating drugs with anti-drug initiatives shared globally. Republic of Korea Despite all our efforts, however, concerns of Korean society which once pinned its hope of winning a war on drugs continue to grow with drug-related arrests and confiscated drugs reaching an all-time high over recent years. Korea is more frequently targeted as the venue for large-scale drug trafficking by organized crime groups using international shipping and air freight services, which fueled the widespread availability and consumption of illegal drugs across the nation. Even more worryingly, the rapidly increasing drug dealing and abuse among the young represented the gravest threat to the government, and online drug transactions displacing street dealers evolve into a sophisticated form of cybercrime via social media, encrypted websites and cryptocurrency which make it tougher for law enforcement to immediately track them. Mr. Chair, Against this backdrop, Korea formed a special unit joined by national relevant agencies including the prosecution to tackle large-scale smuggling by sea or air, online sales and illegal circulation of medical drugs like fentanyl, and the Sentencing Commission of the Supreme Court adopted a new sentencing guideline which seeks a life sentence against drug dealers targeting minors. We also operate an AI-based surveillance system named ‘E-drug monitor’ equipped with a function of the optical character recognition and automatic keywords detection which helps find clues behind drug crimes online. Republic of Korea Promoting a drug policy anchored in human rights the UN urges internationally, Korean drug law enforcement supported by addiction experts provides more effective rehabilitation and treatment tailored to the level of addiction with a view to reintegrating drug addicts back to the society. Mr. Chair, Seeing cannabis legalization as well as possession of internationally controlled drugs with impunity in some parts of the world, we expect international bodies including INCB to closely monitor their ramifying effects and to lead a more consistent response to world drug problems. With incessant drug threats and challenges facing the human race, the Republic of Korea would like to take this opportunity to reaffirm its shared global responsibility to fight drugs and it will try to promote inter-governmental cooperation as well as global networks with regional and international organizations such as UNODC and INCB. Thank you very much. Pledge 4 Action The Republic of Korea pledges to organize the 31st Anti-Drug Liaison Officials’ Meeting for International Cooperation within the next 12 months. This meeting will facilitate the prompt exchange of intelligence on the latest drug-related trends and crimes and enhance cooperation in drug law enforcement among regional drug officials and international organizations, such as the United Nations Office on Drugs and Crime, the International Narcotics Control Board, and the International Criminal Police Organization. Republic of Korea This meeting also aims to address the expansion of national and regional drug trade markets due to a sharp increase in illicit drugs and precursors entering or transiting the Republic of Korea. Regarding one of the newly emerging trends related to drug offenses, as traffickers exploit the dark net, cryptocurrencies, and secure messaging apps for their illegal trade related to cybercrime, the Republic of Korea launched an “E-drug monitoring system” designed to surveil and detect digital clues to online drug crimes. The Republic of Korea hereby pledges to share our achievements and lessons gained by operating the “E-drug monitoring system” with stakeholders, including international bodies and e-commerce platform providers, to promote public-private partnerships within the next 12 months during the abovementioned meeting.

Türkiye: Mr. Chair, Excellencies, Ladies and Gentlemen, Let me congratulate you, Excellency, for assuming the Chairmanship of 67th CND. I assure you of Türkiye’s full support and cooperation. At the outset, I would like to underscore our full commitment to the three international drug control conventions. Their full and universal implementation continues to be crucial for the effectiveness of the system. We believe that 2024 mid-term review will give more impetus to the implementation of our commitments contained in 2019 Ministerial Declaration until 2029. The CND as the primary policy making body and the UNODC as the leading entity for international drug policies should continue to steer our endeavors. We attach utmost importance to the continuation of UNODC’s independent and impartial role. The INCB as well, as a treatymandated monitoring body in the implementation of Drug Control Conventions, should continue to play its vital role. Mr. Chair, We recognize that the world drug problem continues to pose a serious threat to global and regional security and stability, presents challenges to the health and well-being of humanity and undermines sustainable economic development of States. The challenges are ever increasing and recent data cause great concern. We highlight the need to respond to the expanding and diversifying range of drugs and drug markets and increasing risks, including illicit trafficking of synthetic opioids and NPS. We are also witnessing with growing concern the dangerous trend of normalization of drug abuse. In line with SDG target 3.5, in order to strengthen the prevention and treatment of substance abuse and to promote a society free of drug abuse, we need to ensure the full and effective implementation of our commitments. Mr. Chair, Drug problem can be tackled through a multisectoral approach under the principle of shared responsibility and international cooperation. Türkiye hosts UNODC’s Regional Office for South-Eastern Europe – ROSEE in İstanbul since March 2023. ROSEE provides support and expertise on drugs, crime, corruption, criminal justice, and terrorism to countries across South-Eastern Europe. – Türkiye has been a training hub for officials from several countries in the region and beyond. “Turkish International Academy Against Drugs and Organized Crime-TADOC” and “Turkish Counter Narcotics Training Academy-NEA” are important institutions in this regard. We are offering assistance to many countries in their capacity building efforts. -Counter Narcotics Department of Turkish Police has been implementing supply reduction projects, as well as awareness raising campaigns for targeted age groups. -In the fight against the emerging NPS problem, an Early Warning System (EWS) on NPS’ has been conducted successfully since 2008 and together with Generic classification a total of 1.045 NPS type substances has been taken under legal control. -Another area that we focus is to develop technologies for operational risk analysis programs including Artificial Intelligence to tackle the evolving illicit drug trafficking, including the darkweb, online platforms and licit e-commerce platforms. Mr. Chair, Turkish law enforcement authorities continue to successfully seize a significant portion of illicit drugs trafficking through our territory. Within 2023, around 3,3 tons of heroin, 78 tons of cannabis and 21 tons of skunk, 2,5 tons of cocaine, 22,4 tons of methamphetamine, 1,8 tons of synthetic cannabinoid, 5 kiloliters (5 thousand liters) of acetic anhydride, 13,8 millions of amphetamine tablet with Captagon logo and 5,2 millions of ecstasy tablets have been seized. Mr. Chair, The nexus between drug trafficking, and terrorists groups is an important aspect in dealing with this phenomena. It is no secret that terrorists resort to illegal means to finance their activities. The revenue being generated from drug trafficking has become a primary source of terrorist financing. Therefore, Türkiye strongly supports that international cooperation in the fight against drug trafficking should also focus on its nexus with terrorism. There is solid evidence revealing that the PKK/PYD/YPG has an established infrastructure and network to produce, transport and traffic synthetic drugs throughout Europe. Moreover, material evidence and intel info demonstrate that the PKK/PYD/YPG is also engaged in laundering money derived from human and drug trafficking. Mr. Chair, The number of people who require treatment for drug abuse is growing rapidly. Therefore, programs and policies regarding prevention and treatment-rehabilitation services of drug abuse must be drafted and implemented with the meaningful participation of all stakeholders at the national, regional, and international levels. We observe the fruitful collaboration between the UNODC and the Turkish Green Crescent Society, which is a member of the Vienna NGO Committee on Drugs, in contributing to development of more holistic and effective multilateral strategies against substance abuse. TUBİM is also responsible for the preparation of the Annual Türkiye Drug Report which includes all types of data on the fight against drugs and drug abuse. An Early Warning System (EWS) National Working Group is also established within TUBİM to identify and make assessment of new drugs. Mr. Chair, While we gathered here to discuss how to better promote and protect health, safety and wellbeing of humanity, collective punishment and suffering of the Palestinian people continue unabated. We would like to echo the call of the UN Secretary General to “honor the spirit of Ramadan by silencing the weapons and removing all obstacles to delivering humanitarian aid including medicine at the speed and scale required”. Israel must end its military operation in Gaza. We reiterate our demand for an immediate and permanent ceasefire. Safe, unhindered and sustained provision of humanitarian aid into Gaza are more urgent than ever. Using starvation as a war weapon cannot be tolerated. The world must realize that the situation in Gaza is about to become a global catastrophe with repercussions far beyond the region. We call upon Israel to implement the provisional measures ordered by the International Court of Justice without delay and in full. The current crisis once again shows that there can be no lasting peace and security in the Middle East without settling the Israeli-Palestinian conflict on the basis of a two-state solution. And Mr. Chair, As to our pledge: “With a view to enhancing the implementation of all international drug policy commitments, and in addressing the challenges that both the range of drugs and drugs markets are expanding and diversifying and that the abuse, illicit cultivation and production and manufacture of narcotic drugs and psychotropic substances, as well as the illicit trafficking in those substances and in precursors, have reached record levels I pledge for the Republic of Türkiye to organize training programmes within the curricula of Counter Narcotic Training Academy (NEA) along the “pledge4action” period between 2024-2029, in full cooperation with the United Nations Office on Drugs and Crime, the International Narcotics Control Board, and other interested Member States and stakeholders. I also pledge for the Republic of Türkiye to provide training support and share experience through establishing partnership between the Directorate General of Customs Enforcement of Turkish Ministry of Trade and UNODC Passenger and Cargo Border Team (PCBT) Program in 2024.” To conclude, I would like to reaffirm my country’s strong commitment to our common efforts and international cooperation. Thank you.

Algeria: Thank you, chairman. May I congratulate you brother Johnston on your election to the chairmanship of the 67th CND and wish you every success. I thank the secretariat of the UNODC. We align ourselves with both G77 and Africa Group statements.

Would be remiss not to mention the disastrous situation in the Gaza strip. The weapons of hunger and thirst have been used by the occupying force for 5 months. The victims are mainly women and children and the Palestinian people’s rights have been violated. They have seen enough violation of their rights and we call out the double standards. The flouting of the international community values and stripping of their rights. To the brotherly people of Palestine and call for an immediate ceasefire. 

We are pleased with the outcome documentation and we reiterate our commitment to 3 international drug conventions and the framework for the drugs. We need international cooperation and security. To obtain our goals resources must be released and this must be our utmost priority. 

We are concerned with the rise in drug use, particularly synthetic and were an early member of the US led global coalition. Plant-based narcotics such as cannabis, that falls under the 19612 single convention, and NPS. We must push back on cannabis exports and we have seized many tons of cannabis. We have strengthened prevention strategies and brought on civil society. Thank you chair and our pledge is 4 modern centres of drug treatment across the country to provide high-quality drug treatment and will provide for reintegration for drug users. [Original statement here]

Switzerland: Chair, ministers, ladies and gentleman. We would like to give an update on progress made since 2020. We need reliable data on the ground. We would like to thank the OHCHR and their latest report and we also want to thank civil society, particularly IDPC and welcome their latest report. A world free of drugs is unrealistic and contributes to human rights abuses. Human rights should be our compass. We cannot continue on the same road and let the condition get worse. In the 1990s Switzerland had large open market drug markets, we realised our mistakes. As a result we went back to the opening preamble of the 1961 Convention, recognizing the health and well-being of all and developed a 4 pillar approach based on this. We have implemented a policy that protects the health and fundamental rights of our citizens. 20 years later we realised this has reduced heroin use, HIV prevalence and much more. The CND risks losing its relevance by not committing to harm reduction. Our pledge to continue to promote this direction. We will include relevant stakeholders and particularly civil society. [original statement here]

Oman: Peace be upon you all. Mr Chairman, excellencies, distinguished delegates, I have the honour of addressing you Mr Chairman. And to congratulate you on sharing this session on behalf of my country, the Sultanate of Oman, I congratulate you upon your election. We reaffirm the readiness of the Sultanate to cooperate effectively and constructively to guarantee your success in this session and to achieving positive outcomes for the benefit of the international community we are confident that your distinguished skills will enable you to carry out your duties and our joint aspirations are a strong basis for cooperation to the benefit of our communities we express our deep appreciation and gratitude to the executive director of the UNODC and all members of the bureau for their sincere efforts. We highly appreciate the role of the secretariat and the organising committee for the carefulness of their directions. The 67th session of the CND takes place within a dangerous turning point of the drug problem. It is a danger to the security and prosperity of the international community. We must promote international cooperation in combating drugs and the alignment of international laws with international agreements and the directives of international agreements. The Sultanate of Oman is keen to commit completely to the support of international agreements. We are committed to all Arab and international agreements and to participate effectively in effective delivery operations, controlled delivery operations in order to seize and arrest smuggling and trafficking networks. We have adopted a number of steps at the national and international levels including primarily adopting the international strategies as a serious direction to take the necessary steps and prevention methods to limit the negative effects of drugs on Omani society. Our strategy has a number of pillars including its vision and mission statement and strategic goals and four strategic objectives to promote prevention, awareness, treatment, rehabilitation, reintegration, combating drugs, monitoring drugs, carrying out studies, and enabling the implementation of policies and objectives of the strategy. We also have a number of legislations in the form of a law against drugs and psychotropics, a law against money laundering and terrorism, and other relevant laws. As well as preventative and penal arrangements as well as awareness raising. This has all contributed to Oman’s keeping in line with international arrangements as well as combating drugs seriously. The third step is raising the level of the international committee to combat drugs by including the chair of the government units who are in charge of implementing the strategy to improve efficacy and create a society safe of drugs and psychotropics. The national strategy is balanced and in line with international standards and the political declaration and plan of action in order to combat the world drug problem. In terms of demand reduction, we have accorded great attention and we have extended our programs in quality and quantity in line with the development and the crimes of drugs. In addition, reduction of demand included implementing a number of programs and preventative activities as well as training and awareness raising of the danger of drugs in society. This led to educating all sectors of society particularly the youth by promoting their awareness of the dangers of abusing drugs. We also provide and develop treatment and rehabilitation services and treatment and care programs subsequent to drug addiction in the various places in Oman with the participant and coordination of government and provide and civil sectors. Cooperation has led to the creation of several centres for treatment and rehabilitation for people with addiction in order to improve the life of those recovering from addiction and reduce setbacks. We have a priority in our national strategy to training and rehabilitating former drug abusers. We affirm the primary role of the CND as a policy making body of the UN and we affirm our commitment to the three international conventions as a foundation for international policies to combat drugs. We reaffirm our commitment to combat drugs at the national and international levels while paying attention to health and humanitarian aspects. [original statement here]

Germany: Mr Chairman, Madam Executive Director, Excellencies, Ladies and Gentlemen, We all wish for a perfect world, a world where drug-related challenges would not deter our progress, or impact the health and welfare of humankind. And, actually, we have all worked very hard for this aspiration to become a reality. Nevertheless, today we see that: • The illicit production and trafficking of drugs is record high. • Organized crime continues to threaten the progress made with democratic institutions. • And thousands human beings continue to die due to drug use or associated diseases! Again, and again, we notice: Simple, unilateral solutions do not deliver! The world drug situation is complex, and – no wonder – successful policies must therefore be balanced, integrated and comprehensive, too. More than ever, we need to fight together against drug cartels by stepping up cooperation between origin, transit and destination countries of illicit drugs. And it is high time to accelerate all efforts in the fields of demand reduction, too: through evidence-based prevention, harm reduction, counselling and, of course, treatment! And, whatever we do, we have to recognize how interrelated issues are and integrate our knowledge of the drivers and causes in our policy, on both sides – drug supply and drug demand. We must address causes and not just the symptoms! In Germany, we strive for an evidence-based, integrated, balanced and comprehensive drug and addiction policy: • We combat organised crime and drug trafficking by stepping up police cooperation and we continue to monitor current challenges and strengthen our preparedness regarding synthetic drugs, NPS and other challenges that threaten our public health and security. • At the same time, we strongly improve our prevention and harm reduction approach, for instance, with a new cannabis policy and by having introduced a federal legal framework for scientifically supported model projects on drug checking. • and as in the past years, Germany, together with Peru and Thailand are co-tabling a resolution which focuses on future perspectives on how to effectively implement the UN Guiding Principles on AD and therefore focus on the causes of the issue. I kindly request your support for this resolution. Ladies and Gentlemen, Nothing is perfect, we must constantly adapt and improve. Let us use this Mid-Term Review to take an honest look at how much progress has been made but more importantly, how we can use evidence to attain more balanced, more integrated, more comprehensive and hence a more successful and sustainable drug policy! And finally, on behalf of the Federal Government of Germany, it is my pleasure to proclaim a twofold pledge4action to address both demand and supply aspects: “With a view to enhancing the implementation of all international drug policy commitments, and in addressing our common challenges, I pledge for Germany: • To increase the 2024 budget of our federal government for drug and addiction prevention measures by 6 million euros. • And in order to better prepare for future challenges to start a national project called “Agent K” to analyse the growing and evolving narcotic threat of Ketamine and work on science-based strategies to tackle these.

Austria: Chair, Excellencies, Distinguished Colleagues, Dear Delegates and members of civil society, Austria is fully aligned with the Statement delivered by the EU, the Joint Statement delivered by Colombia and the Joint Statement of the Global Coalition delivered by the United States. Let me congratulate you, Mr. Chair and the other bureau members upon your election. And let me congratulate you for your outstanding work on the adoption of the outcome document. Let me also thank you and the Secretariat for convening this meeting and your efforts to ensure lively discussions. I also want to stress our appreciation for the excellent cooperation with UNODC and thank Executive Director Ghada Waly for promoting the important work of the Commission on Narcotic Drugs. We are gathering at this CND meeting to review the implementation of our joint policy commitments. Austria recognizes the complex nature of the world drug situation which involves health, security, social, economic and human 3 rights aspects. We must address all these important aspects, especially at the time of the Midterm-Review. An effective response requires international cooperation – among Member States, with relevant UN agencies and with civil society. Let me emphasize once more that Austria is strongly committed to a human rights based approach to drug control. Respecting Human Rights means avoiding any stigmatization of addicted people and giving them maximum support. The goal of the Austrian Drug Policy is to create a balance between criminal prosecution and health- and social policy measures to tackle drug addiction. We support penalties against organized drug trafficking but not against drug consumers themselves. The UNGASS 2016 outcome document and the Ministerial Declaration 2019 play important roles and call for the principle of proportionality in drug policies. To reduce demand for drugs we focus on addiction prevention, a task that concerns our entire society. The majority of 4 prevention measures implemented in Austria are aimed at the promotion of life skills and social learning in children and young people. They also aim to raise awareness of high-risk behaviour. We operate life skills programmes for children and young people of all ages starting already in kindergarten. It is of great importance that drug control conventions are consistent with international human rights standards. We therefore welcome the participation of the Office of the United Nations High Commissioner for Human Rights, namely High Commissioner Volker Türk, at the Midterm-Review. The High Commissioners report on “human rights challenges in addressing and countering all aspects of the world drug problem” highlights important issues. Focusing on human rights concerns at the CND, leads to a balanced approach to this complex issue. Finally, Mr. Chair, it is my pleasure and honour to support the Pledge4Action Initiative, which you have conceived especially for this Midterm Review. I would like to deliver the following two pledges on behalf of Austria: 5 With a view to enhancing the implementation of all international drug policy commitments and in addressing the challenge that drug treatment and health services continue to fall short of meeting needs and deaths related to drug use have increased – Austria pledges to further expand standardized training by trainers accredited under the European Prevention Curriculum for professionals who are involved in shaping prevention decisions, opinions and policies in Austria. In the spirit of Austria’s long-standing and continued commitment to the UN JPO program, Austria pledges to support UNODC with personnel in the Drug Control and Crime Prevention/Border Management Branch.

Costa Rica: Chair, my country would like to thank you for your leadership. We align with G77 and Panama GRULAC statements. Drugs affects all areas of life and this needs sustainable development approaches and that will advance the SDGs. Illicit drug markets continue to grow. Drugs contribute to instability, violence, crime and environmental degradation. We need urgent collaboration that is based on the best evidence available. Costa Rica supports the US synthetic drugs coalition. We support prevention and recovery and work to control the manufacturing of drugs. It’s a cross cutting issue and needs to be tackled with the broadest mandate. We have a national strategy recognizing that the only way forward is only. We are focused on decriminalisation, gender sensitivity, harm reduction and  children. We have strict controls on the import and export of precursors and all things associated with drug production. We must incentivize international cooperation. Our country and the region needs timely public health interventions. We need to focus on policies that have a human focus, human and social development. [Original statement here]

Kuwait: Our commitment to the content of the Conventions as the cornerstone in addressing the WDP represent the bedrock on which our policy is promulgated to combat drugs. We are committed also to the 2009, 2014, 2016, and 2019 documents framing our international strategy, in view of the 2029 goals. Combating drugs should honour international instruments on the matter. National legislation compliments this, to eliminate drug abuse. National sovereignty and the UN Charter and non-interference principle are very important for us. Taking into consideration domestic legal systems. In Kuwait, law enforcement operators who monitor and track dealers, and their ingenious methods, follow best practices. Statistics show the cases of seized drugs and individuals arrested. In 2022, we established a Higher Committee for the Anti-Drug Campaign. A centre for the treatment and rehabilitation of addicts under the MInistry of Interior with the participation of other ministries, civil society and other stakeholders. Raising awareness on the impact of drugs and combating and eradicating this poison, treating addicts, providing for their rehabilitation and reintegration. We provide services to citizens and residents, admitted voluntarily or referred to these centres by law. And provide sustainable treatment plans for those who seek recovery and reintegration. Kuwait believes on the importance of raising awareness and prevention through early states, including via families and schools. Starting in the family environment and school settings, we organise activities to raise awareness on the risks and impacts of drugs, media campaigns designed by specialists, in collaboration with private, academy, civil society and other stakeholders. Connections between transnational organised crime and trafficking are evident, corruption, terrorism. Capacity development is of utmost importance to bolster security control. This meeting is held after having adopted a Ministerial Declaration by consensus that reiterates the principles of the UN charter and human rights. That is the right to life, to healthcare, when designing policies about drugs. However, our brothers and sisters in Palestine are impacted, suffering from the Israeli aggression that kills children and women, targets infrastructure, healthcare institutions, hospitals, depriving them from healthcare. Equally, faced with a dire situation, emanating from this long aggression. Lack of food, medical equipment and medicines. Violent and blatant violation of human rights and humanitarian law. International community must honour its commitments under the treaties and call for the opening of safe humanitarian corridos for aid, much needed.

United States of America: Executive Director Waly, Ambassador Johnson, representatives of fellow Member States: today marks the first time a U.S. Secretary of State has taken part in a session of the UN Commission on Narcotic Drugs. I’m here because, more than ever, fulfilling the mission of this institution is critical to the security, prosperity, and health of the American people, just as it is to people of all nations. Since the Commission’s last high-level session three years ago, the number of Americans who died of overdoses caused by synthetic opioids has nearly doubled – to 74,000 people over that year. More than 40% of our people know someone who died from an opioid overdose. Synthetic drugs are now the number one killer of Americans aged 18 to 45.  Many of you are here for similar reasons. The types of synthetic drug afflicting your nations may vary. In some, it may be methamphetamine or ketamine, in others, tramadol, captagon, or fentanyl. The scale of the problem may be different. But in every region, use, dependence, and overdose deaths by synthetic drugs are all rising rapidly. My message to this gathering is urgent. If we want to change the trajectory of this crisis, there is only one way to succeed: together. For every nation, the work starts at home. Including in the United States. Over the past three years, we’ve invested an unprecedented $169 billion to combat harmful drugs. Under President Biden, the U.S. is – for the first time – dedicating more resources to tackling the demand for drugs than to halting the supply.  That means more resources for public awareness, health interventions, and services to prevent and reduce drug use, overdoses, and other harms, alongside measures to prevent, detect, and stop illicit manufacturing and trafficking. This reflects the fundamental fact that untreated substance use and rising trafficking are two sides of the same coin. The more we help people break the cycle of use and dependence, the smaller the illicit market for drugs will be. And the more we can reduce the illicit supply of harmful drugs, the fewer people will be exposed to them. Yet while our efforts to address the synthetic drug crisis start at home, they can’t end there. This is a problem no country can solve alone. The criminal groups that produce these drugs are agile. When a country cracks down on the production of synthetic drugs or their chemical precursors, criminals quickly find another place to produce them. When one trafficking route is shut down, they shift to another.  They are constantly creating new drugs, too. Criminal organizations produce around 80 new synthetic drugs every year – many more potent than the ones already circulating. And they are always looking for new markets and new users to boost their profits. So, if we want to protect the people in all our countries, we can’t go it alone. Here are four ways we can work together to take effective action. First, we can accelerate efforts to regulate the precursor chemicals used to illicitly make synthetic drugs. We’ll have a chance to do that next week, when the CND will vote on adding new and emerging precursors to the list of chemicals we already control. Doing so places responsibility on governments to monitor the manufacturing and trade of these chemicals to reduce their use for illicit purposes – which makes them harder to traffic. We urge every member to support this effort – and to fulfill its obligations to control these substances. Second, we can redouble our efforts to reduce overdose deaths. A growing body of evidence demonstrates how we can bring together prevention, harm reduction, treatment, and recovery support to save lives. Next week, we’ll sponsor a resolution calling on countries to implement measures like these. Join us in adopting it. Third, we can deepen collaboration with key actors outside of government. Public health professionals, civil society groups, affected communities, academics, and other experts have long led the way in identifying effective solutions. We must do more to partner with them, and with the private sector, particularly given the central role private sector platforms and products play in the illicit manufacture, movement, and marketing of synthetic drugs. The U.S. and the UNODC recently launched a new collaborative effort with Meta, Snap, and others to disrupt synthetic drugs activity online – and instead use their influence to educate users about the risks. We hope you’ll be part of it, and encourage more platforms to come on board. Finally, join the 151 countries and 14 international organizations in the Global Coalition to Address Synthetic Drug Threats. Since last July, we’ve been working to identify ways we can cooperate to prevent the manufacturing and trafficking of synthetic drugs, detect emerging threats, and strengthen public health interventions. Together, the Coalition has developed specific recommendations for actions countries can take, as well as identified more than 120 initiatives to support these efforts. Now, we’re moving to implement the actions. Partner with us. I opened by highlighting the catastrophic rise in overdose deaths in the United States. But that’s not where the story ends. Recent data suggests that – for the first time in years – the number of Americans who died of overdoses did not increase significantly. The number leveled off. With one American still dying of a drug overdose every five minutes, our work is far from finished. But the change suggests that steps we are taking – many in partnership with countries here – are turning the tide. That is why we will keep pressing forward with efforts like the ones I described today. And for the health, security, and prosperity of people in your countries, I hope will join us. Thank you.